RXRX
Price
$4.05
Change
+$0.08 (+2.02%)
Updated
Sep 22 closing price
Capitalization
2.07B
49 days until earnings call
Intraday BUY SELL Signals
XBIO
Price
$2.57
Change
-$0.42 (-14.05%)
Updated
Sep 22 closing price
Capitalization
6.49M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXRX vs XBIO

RXRX vs XBIO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RXRX vs. XBIO commentary
Sep 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Buy and XBIO is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
XBIO: Fundamental Ratings
XBIO
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXXBIO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 23, 2026
Stock price -- (RXRX: $3.97 vs. XBIO: $2.99)
Brand notoriety: RXRX and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 202% vs. XBIO: 173%
Market capitalization -- RXRX: $2.07B vs. XBIO: $6.49M
RXRX [@Biotechnology] is valued at $2.07B. XBIO’s [@Biotechnology] market capitalization is $6.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green while XBIO’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than XBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 6 TA indicator(s) are bullish while XBIO’s TA Score has 5 bullish TA indicator(s).

  • RXRX’s TA Score: 6 bullish, 3 bearish.
  • XBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than XBIO.

Price Growth

RXRX (@Biotechnology) experienced а +16.42% price change this week, while XBIO (@Biotechnology) price change was -30.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +27.63%. For the same industry, the average monthly price growth was -6.27%, and the average quarterly price growth was +7.77%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 11, 2026.

XBIO is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Biotechnology (+27.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
RXRX
Daily Signal:
Gain/Loss:
XBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BATRK52.221.65
+3.26%
Atlanta Braves Holdings
NVNO9.050.07
+0.84%
enVVeno Medical Corporation
ROKU154.330.69
+0.45%
Roku
CCB45.14-0.83
-1.81%
Coastal Financial Corp
HDRN1.49-0.23
-13.37%
Hadron Energy Inc.